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Abstract - Study objectives: Oral appliances
have gained their place in the treatment of
obstructive sleep apnea (OSA) where custom-made
titratable mandibular advancement devices (MAD)
have become the oral appliance of choice. This study
aimed to asses the value of the drug-induced sleep
endoscopy (DISE) using a MAD in the prediction of
treatment outcome for OSAHS
Methods: This is a prospective, single-center
cohort study that enrolled sixty-six consecutive
patients with diagnosed OSA (5 events/h < apneahypopnea index (AHI) < 50 events/h) to be treated
with a custom-made titratable MAD. The patients
were evaluated polysomnographically with the MAD
in situ after the adaptation and titration period of 3
months. The associations between findings during
DISE and treatment outcome were assessed
Results: The subjects showed a wide range of
severity of OSAHS pre-treatment: median AHI was
43.10 with a range from 20.13 to 66.07. The
simulation bite was associated with a significant
increase in cross-sectional area at level of the
velopharynx, tongue base and epiglottis. MAD
treatment response in the studied population was
91%, with a mean AHI improving from 43.10 to
12.93.
Conclusions: Drug-induced sleep endoscopy
with simulation bite is an acceptably reproducible
technique for determining the sites of obstruction in
OSAHS subjects; it thus offers possibilities as a
prognostic indicator for treatment with MAD

Keywords: oral appliance, drug-induced sleep endoscopy,
nasendoscopy, simulation bite, obstructive sleep apnea
I. INTRODUCTION
Obstructive sleep apnea/hypopnea syndrome
(OSAHS) is characterized by recurrent episodes of apnea
and hypopnea during sleep, due to repetitive upper airway
(UA) collapse, often resulting in decreased oxygen blood
levels and arousal from sleep [1,2]. Continuous positive
airway pressure (cPAP) therapy is considered the gold
standard for treatment, but oral appliance therapy could
represent the main alternative treatment modality.
Mandibular advancement devices (MADs) are the most
common class of oral appliances to treat OSAHS [3-5]; in
selecting patients who might benefit from MAD
treatment, several predictor factors of treatment outcome
have been described in the literature, such as lower apnea–
hypopnea index (AHI), lower body mass index (BMI),
lower age, female gender and supine-dependent OSAHS
[6,7]. Firstly described in 1991 by Croft and Pringle, sleep
nasendoscopy or drug-induced sleep endoscopy (DISE)
can be used to identify the level of snoring and UA
collapse; a “chin-lift” manoeuvre (mandible actively
guided forward by “grasping” it and advancing it to a
maximal protruded position) can be added to the DISE
procedure [8]. Some authors considered DISE a good
technique for researchers to assess the site and the pattern
of collapse, but they suggest that it should be correlated to
clinically available measures, such awake nasendoscope
to validate this.
The aim of this paper is to assess the value of the DISE
using a MAD in the prediction of treatment outcome for
OSAHS.
II. METHODOLOGY

Sixty-six consecutive patients admitted to our
Department with diagnosis of OSAHS were enrolled in
the study. Sleeping Breath Disorders diagnosis was based
on polysomnography (PSG)(ApneaLink Air. ResMed,
Germany.). Parameters assessed were: AHI (Apnea
Hypopnea Index) corresponding to average of apneas and
hypopneas per hour of sleep; ODI (Oxygen Desaturation
Index) which was expression of the number of
desaturation events (> 3%) per hour of sleep; NADIR (the
lower O2 saturation level).
OSAHS is defined by an AHI > 5h/sleep; baseline
characteristics are shown in Table I.
Inclusion criteria were: >18 years of age, a confirmed
diagnosis of OSAHS (AHI > 5h/sleep), prepared to wear a
MAD, sufficient healthy teeth to allow MAD construction.
We excluded patients with history of poorly controlled
epilepsy, history of allergy to metals, edentulous or with
insufficient teeth.
The study was approved by the Ethics Committee. All
patients gave written consent.

!
DISE with simulation bite
The technique of sleep nasendoscopy (SNE) was
developed by Croft and Pringle in 1991: subjects are
pharmacologically induced into a light phase of sleep, and
the UA are directly visualized using a flexible fiber-optic
endoscope. Levels of partial or complete obstruction are
noted and the following grading scheme is applied: grade
1: palatal level snoring, grade 2: palatal level obstruction,
grade 3: multi-segmental involvement – intermittent oroand hypopharyngeal collapse, grade 4: sustained multilevel collapse, grade 5: tongue base obstruction [9]. An
improvement of the nasendoscopic procedure has been to
gently advance the mandible during sedation to mimic the
effect of MAD and to examine the effect of this
manoeuvre on UA patency and snoring: if airway
dimensions improve and snoring is reduced, MAD may be
indicated, regardless of the exact grading.
Artificial sleep was induced by intravenous administration
propofol through a target-controlled infusion system in the
operating room, with the patients in the supine position,
with peripheral venous punction, monitoring oxygen

saturation, cardiac rhythm and Bispectral Index (BIS).
BIS monitoring provides direct information about the
effects of anesthetics and sedatives on the brain by placing
a sensor on a patient's forehead [10,11]. The BIS monitor
translates the information from electrical brain activity
into a single number from 100 (indicating an awake
patient) to 0 (indicating the absence of brain electrical
activity). The search value during DISE ranged from 50
to 70.
When adequate sedation had been achieved, a
nasolaryngoscope (Olympus ENF-GP, diameter 3.7 mm;
Olympus Europe GmbH, Hamburg, Germany) was passed
without local anaesthetic through the more patent nostril
identifying the level(s) of any obstruction. Video-editing
software was used to capture frames from the digital video
recording of the nasolaryngoscopy.
All endoscopic findings have been classified according to
the VOTE classification [12,13] which considers the
following sites of obstruction: Velum, Oropharynx,
Tongue base, Epiglottis. For each structure the minimal
sectional area has been classified in 3 obstructing grades:
• grade 0: no obstruction;
• grade 1: partial obstruction;
• grade 2: complete obstruction.
Identification of the obstructing configuration was
evaluated according to the shape of the dynamic collapse
(antero-posterior, lateral or concentric when combination
of the former two).
The DISE was preceded by the registration of a simulation
bite for each patient. A customized, removable, Herbst
appliance was created for each subject with the mandible
in a position of maximum, comfortable protrusion. The
patients were educated to protrude the mandible forward
toward the maximal comfortable protrusion (MCP). We
repeated three times and recorded this position.
Baseline DISE was complemented with the use of intraorally simulation bite, placed by a dentist and preceded by
intravenous administration of sedative drugs, in order to
avoid jaw clamping or waking up the patient.
In the first phase of DISE we assessed the UA dimensions
with the intra-orally simulation bite. The simulation bite
was then removed, allowing assessment of the UA without
any mandibular repositioning.
Mandibular advanced device (MAD)
A custom-made mandibular advancement device (MAD)
was fit for each patient; this consists of two dental clips
(attached to each other) with an adjunct for adjust the
manipular protrusion in the frontal teeth area. The patient
needed three months to acclimatize with MAD; during
this period, the adjunct was assessed to obtain a maximal
comfortable protruded mandibular position or a resolute
of the apneas.
Evaluation
The patients were evaluated by an ambulatory
polysonnography with the MAD in situ after the threemonths adaptation and titration period. The associations
between findings during DISE and treatment outcome
were assessed. We considered as a treatment response a
50% reduction in AHI and an AHI value >20 [14].

III. RESULTS
The subjects showed a wide range of severity of OSAHS
pre-treatment: median AHI was 43.10 with a range from
20.13 to 66.07 (Table II).
!

The presence of palatal (concentric or antero-posterior)
and tongue base antero-posterior collapse at baseline
evaluation was associated with greater response to
treatment, while the presence of oropharynx-lateral walls
collapse at baseline evaluation showed a tendency towards
an association with a less favourable treatment outcome
(Table V).

!
Of sixty-six patients, the most suffered form severe
OSAHS (45.4%), while seventeen patients (25.8%) and
nineteen patients (28.8%) suffered from moderate and
mild OSAHS respectively (Table III).

!
The DISE without simulation bite showed most frequently
antero-posterior collapse at the level of the tongue base, a
lateral collapse of the oropharynx lateral walls and a
concentric collapse at the level of the palate. We found
combined collapses in 65% of patients.
The simulation bite was associated with a significant
increase in cross-sectional area at level of the
velopharynx, tongue base and epiglottis. MAD treatment
response in the studied population was 91%, with a mean
AHI improving from 43.10 to 12.93 (Table IV).

!
IV. DISCUSSION
OSAHS is defined as a disorder characterized by
repeated collapse of the UA during sleep, with periodic
apnea of breathing [15]. Depending on the severity of the
condition, patients can be managed by nasally applied
continuous positive airways pressure (nCPAP),
mandibular advancement device (MAD) therapy or a
range of surgical techniques [16,17].
Although less efficacious than CPAP, MADs are a simpler
and often a more acceptable treatment modality, and it can
represent a rescue therapy in patients with mild to severe
OSA who are reluctant or non-responding to CPAP, or fail
to use CPAP [18]. There has been increasing evidences
about the use of MADs for the therapy of OSAHS and this
treatment modality has been shown be more beneficial on
polysomnographic indices of OSAHS, subjective and

objective measures of sleepiness, blood pressure,
neuropsychological functioning and quality of life.
Overall, ~60–70% of patients achieve a reduction of
≥50% in AHI, with a reduction of AHI to <5 events h-1 in
35–40% of patients [19-21].
MADs are worn intra-orally during the night and
mechanically protrude the mandible, commonly with a
design to gradually protrude the mandible applying a
mechanical advancing mechanism, to prevent UA collapse
and increase the cross-sectional airway dimensions, and
thereby reduce snoring and obstructive sleep apneas [22].
Soft tissue structures within the palatoglossal and
palatopharyngeal arches connect the mandible, tongue,
lateral pharyngeal walls and soft palate; it has been
proposed that such soft tissue connections may be
stretched by mandibular advancement [23,24].
Using cephalometry, Tsuiki et al. [25] concluded that an
anteriorly titrated mandibular position reduced obstructive
sleep apnea severity, enlarged the velopharynx and
decreased the curvature of the anterior velopharyngeal
wall in good responders [5]. As the tongue is brought
forwards, the soft palate will tend to follow to maintain a
posterior oral seal, providing variable improvement in
individuals with multi-level involvement [26]. This would
explain the findings of Henke et al [27] that the MAD
could be effective where the sites of obstruction include
the velopharynx, and supports the more varied response
observed here in subjects with multi-level involvement.
Several methods have been proposed to evaluate the effect
of MAD on UA patency to predict its efficacy in the
treatment of OSAHS. Although helpful in selected
subjects, neither CT nor MRI can be justified routinely on
the basis of expense, limited access and, in the case of CT,
relatively high doses of radiation.
Anneclaire et al. [3] evaluated the associations between
the findings during sleep nasendoscopy with simulation
bite and treatment outcome. They reported a higher
percentage of collapse at the level of the palate, followed
by the tongue base and the epiglottis, while the
oropharynx level was reported less commonly. There were
several combinations of collapse levels, and the most
frequent pattern was the combination of palatal and
tongue base collapse (34.4%), while multi-level collapse
in general was noted in 87.2% of all patients. In the
present study, we reported a higher percentage of anteroposterior collapse at the level of the tongue base, a lateral
collapse of the oropharynx lateral walls and a concentric
collapse at the level of the palate.
When UA collapse was completely resolved using the
simulation bite, the patient was considered a “well
suitable” candidate for MAD treatment; patients with a
partial resolution (residual collapse at one or more UA
levels) were considered as “partially suitable”; patients
were considered “not suitable” when UA collapsibility
increased or remained unchanged with the simulation bite
in situ.
They defined treatment response as a reduction in AHI
following MAD treatment of ≥50% compared to baseline;
overall MAD treatment response in the studied population
was 68,9%, with a mean AHI improving from 21.4 to 8.9
h1 sleep. The presence of palatal collapse at baseline
evaluation was associated with treatment response, while

presence of hypopharyngeal collapse at baseline
evaluation showed a tendency towards an association with
a less favourable treatment outcome. The results of this
study demonstrated a statistically significant association
between a positive effect of the simulation bite on the UA
patency during sleep nasendoscopy and treatment
response with MAD (P < 0.01). We observed a positive
response to treatment with MAD in 86.7% of anteroposterior velum collapse, 80% of concentric velum
collapse, and 93.3% of antero-posterior tongue base
collapse.
Ama et al. [28] evaluated the role of SNE in conjunction
with mandibular protrusion to predict the success of MAD
therapy in the treatment of patients with OSAHS; Chan et
al [19] evaluated the role of MAD on UA anatomy using
nasopharyngoscopy performed during wakefulness in
patients with OSAHS and the potential role of this
approach for identifying responder and nonresponder
subjects, finding that the increase in the velopharyngeal
cross-sectional area caused by mandibular advancement
was significantly associated with a treatment response on
polysomnography, while an increase in the cross-sectional
area of the oropharynx or hypopharynx was not
significantly associated with treatment outcome.
The results of our study suggest that the mandibular
advancement manoeuvre during DISE could help to
optimise the selection of patients for oral device
treatment.
The major flaw of this study is that the assessment of the
UA during sleep nasendoscopy is based on subjective
findings.
V. CONCLUSION
The development of a simple and clinically
useful tool to predict which patients will respond to MAD
therapy would aid the appropriate selection of patients.
Drug-induced sleep endoscopy with simulation bite is a
reproducible technique to assess the sites of obstruction in
OSAHS patients, and it can be used as a prognostic
indicator for treatment with MAD.
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